D.A. Davidson & Co’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,296
Closed -$55K 2396
2016
Q4
$55K Sell
1,296
-28
-2% -$1.14K ﹤0.01% 1558
2016
Q3
$54K Sell
1,324
-296
-18% -$12.4K ﹤0.01% 1488
2016
Q2
$64K Sell
1,620
-92
-5% -$3.31K ﹤0.01% 1313
2016
Q1
$57K Buy
1,712
+8
+0.5% +$249 ﹤0.01% 1341
2015
Q4
$57K Sell
1,704
-208
-11% -$6.5K ﹤0.01% 1349
2015
Q3
$56K Sell
1,912
-945
-33% -$29.5K ﹤0.01% 1317
2015
Q2
$78K Sell
2,857
-561
-16% -$14.9K ﹤0.01% 1252
2015
Q1
$86K Sell
3,418
-254
-7% -$6K ﹤0.01% 1199
2014
Q4
$81K Sell
3,672
-34
-0.9% -$689 ﹤0.01% 1226
2014
Q3
$75K Sell
3,706
-879
-19% -$17.5K ﹤0.01% 1240
2014
Q2
$88K Sell
4,585
-293
-6% -$5.46K ﹤0.01% 1206
2014
Q1
$91K Sell
4,878
-1,280
-21% -$24.7K ﹤0.01% 1182
2013
Q4
$120K Sell
6,158
-780
-11% -$14.3K ﹤0.01% 1002
2013
Q3
$114K Sell
6,938
-37
-0.5% -$594 0.01% 859
2013
Q2
$104K Buy
+6,975
New +$102K 0.01% 860

Other funds holding IART

D.A. Davidson & Co's IART Position: Q1 2017 in Review

D.A. Davidson & Co sold out of Integra LifeSciences (IART) in Q1 2017, closing a stake of 1,296 shares — an estimated $55K sold.

D.A. Davidson & Co first reported a position in IART in Q2 2013 and held it in 15 quarters. The position peaked at $120K in Q4 2013. 236 funds tracked by Wall St. Rank hold IART as of Q1 2017.

  • D.A. Davidson & Co reported no remaining Integra LifeSciences position as of Q1 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 1,296 Integra LifeSciences shares in Q1 2017, an estimated $55K.
  • D.A. Davidson & Co first reported a position in Integra LifeSciences in Q2 2013 and held it in 15 quarters.
  • D.A. Davidson & Co's Integra LifeSciences position peaked at $120K in Q4 2013.
  • 236 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2017.

Based on D.A. Davidson & Co's 13F filing for Q1 2017, filed 12 May 2017.